MedTrace Logo

Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency

NCT02321865 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2019-04-16

No results posted yet for this study

Summary

The objective of this study is to check the dose control method of NPC-02 and the holding effect for the target serum zinc concentration in patients with zinc deficiency.

Conditions

  • Zinc Deficiency

Interventions

DRUG

NPC-02

Sponsors & Collaborators

  • Nobelpharma

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-21
Primary Completion
2015-11-30
Completion
2015-11-24

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02321865 on ClinicalTrials.gov